AF Association News & Events
New patient survey results show 80% of AF patients say ‘YES’ to the freedom that INR self-monitoring gives them
The purpose of this survey was to help discover patient thoughts and opinions about INR self-monitoring versus clinic visits. Several trials have demonstrated that patient self-monitoring (PSM) by those on long term warfarin significantly improves time in therapeutic range (TTR) and leads to better management outcomes.
Pharmacists Demand Radical Reform of Care For People With Long Term Conditions
Community pharmacists must be able to routinely prescribe medicines for people with long term conditions and refer them directly to other healthcare professionals to ease the overwhelming demand facing the NHS says the Royal Pharmaceutical Society (RPS) in a new report to be launched at the House of Commons on 30th November.
New medical grade single lead ECG on your WRIST helps discover possible Atrial Fibrillation, a leading cause of stroke in the UK
Arrhythmia Alliance places 3000th Public Access Defibrillator on World Restart the Heart Day
“AEDs must be as commonplace as fire extinguishers and smoke alarms if we are to dramatically reduce the number of deaths from sudden cardiac arrest in the UK.”
New real-world analysis reports lower risk of major bleeding with dabigatran compared to rivaroxaban in stroke prevention
Ingelheim, Germany, 13.October 2016 – A large observational study by researchers from the U.S. FDA has found that dabigatran (150 mg twice daily) was associated with lower rates of intracranial haemorrhage and major extracranial bleeding, including major gastrointestinal bleeding than rivaroxaban (20 mg once daily) in patients with atrial fibrillation (AF). The study is the largest observational study to-date comparing the two drugs, and analysed data from over 118,000 AF patients. Based on the data published in JAMA Internal Medicine, the accompanying Editor’s Note written by Parks and Redberg suggests that physicians should “prescribe dabigatran over rivaroxaban for patients with atrial fibrillation.”
HEART RHYTHM CONGRESS DEBATES NEED FOR SCREENING OF UNKNOWN OR UNDIAGNOSED ATRIAL FIBRILLATION (AF)
Thursday 13 October, Heart Rhythm Congress, Birmingham, UK: Many of the world’s leading authorities on the management and treatment of atrial fibrillation (AF) met at the Heart Rhythm Congress to debate the latest evidence supporting the value of screening for people with unknown AF.
UK’S LEADING HEART RHYTHM CHARITY AND CARDIAC SPECIALISTS CALL FOR AN URGENT RETHINK BY NHS ENGLAND ON ITS PILOT TECHNOLOGY EVALUATION PROCESS
Thursday 13 October: Birmingham, UK: Arrhythmia Alliance, the UK’s leading heart rhythm charity, and many of the UK’s leading cardiac specialists are calling on NHS England to reconsider its ‘Commissioning through Evaluation’ process, which as of next month will leave hundreds of AF (Atrial Fibrillation) patients at serious risk of suffering a debilitating AF-related stroke.
HRC Launch Announcement
Today, more than 3,000 heart rhythm experts and healthcare professionals from around the world have come together at the ICC, Birmingham, for the annual Heart Rhythm Congress, the UK’s largest educational congress devoted solely to heart rhythm disorders.
International Heart Rhythm Congress Calls For Urgent Action To Prevent Thousands of Unnecessary Deaths From Arrhythmias
Thursday 29 September, World Heart Day, Birmingham, UK: Over 3,000 heart rhythm experts and healthcare professionals from around the world will converge on the ICC, Birmingham, for the annual Heart Rhythm Congress (HRC), 9-12 October, the UK's largest educational congress devoted solely to heart rhythm disorders.
Joint Statement from Arrhythmia Alliance and British Heart Rhythm Society
The recent announcement of cost savings by the NHS through a national procurement approach should be commended in principle. However, A-A & BHRS calls for clarification and reassurance that patients and local services will not suffer due to clinical experts not being able to access or provide the most appropriate device for the needs of the specific patient.